About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in California | 679 Studies

Clinical Trials Pancreatic CancerCalifornia

Pancreatic Cancer Clinical Trials in California

Find 679 clinical trials for pancreatic cancer near California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 281-300 of 679 trials

Active not recruitingA Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C MutationA Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of…NCT05485974·Encinitas, California and 13 others CompletedS9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003018·Mobile, Alabama and 83 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of MGC028 in Participants With Advanced Solid TumorsThe goal of this clinical trial is to characterize the safety, tolerability, dose-limiting toxicities (DLT), and maximum tolerated dose (MTD) or maximum administered dose of…NCT06723236·San Francisco, California and 6 others

CompletedBevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With GemcitabineRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00365144·San Francisco, California

CompletedARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerThe study will document the safety and efficacy of the combination of ARQ 501 and gemcitabine in patients with treatment-naïve, unresectable, metastatic pancreatic adenocarcinoma.NCT00102700·Mobile, Alabama and 14 others

CompletedYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyThis research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the…NCT02685631·Birmingham, Alabama and 41 others

TerminatedNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsThe purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors and a pathogenic or likely…NCT05169437·Yuma, Arizona and 79 others

TerminatedA Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, First-In-Human (FIH), Phase 1a/1b study of PY159 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are…NCT04682431·Los Angeles, California and 16 others

UnknownU01-Biomarkers for Noninvasive and Early Detection of Pancreatic CancerThis is an observational, biospecimen collection protocol to develop a bank of pancreatic cancer tissue and normal tissue.NCT03886571·Newport Beach, California

CompletedBrightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or BladderThis study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder.NCT05512377·Mobile, Alabama and 59 others

CompletedImmunotherapy Study for Surgically Resected Pancreatic CancerThe purpose of this study is to assess overall survival after treatment with a regimen of adjuvant therapy (Gemcitabine alone or with 5-FU chemoradiation) with or without…NCT01072981·Birmingham, Alabama and 74 others

CompletedTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersThis is a phase 1/1b open label, multicenter dose escalation and dose expansion study to investigate the safety, tolerability and anti-tumor activity of TPST-1120, a small…NCT03829436·San Francisco, California and 10 others

RecruitingA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)This study will check how well a new medicine, Risvutatug rezetecan, (Ris-Rez, also known as GSK5764227) works, how safe it is and how the body handles it in participants all…NCT06885034·Los Alamitos, California and 84 others

TerminatedFeasibility of Using Real-time Cine-MRI for Treating Moving & Deforming TumorsThis study aims to investigate and optimize imaging sequences and parameters of rapid real-time MRI in order to obtain adequate guidance for accurately and precisely delivering…NCT01071434·Stanford, California

CompletedA Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic AdenocarcinomaThis study will compare the efficacy of simtuzumab (GS-6624) versus placebo in combination with gemcitabine in adults with pancreatic cancer.NCT01472198·Birmingham, Alabama and 56 others

CompletedStudy of PEP02 as a Second Line Therapy for Metastatic Pancreatic CancerThe purpose of this study is to see the effect of PEP02 in the treatment of metastatic pancreatic cancer.NCT00813163·San Francisco, California and 2 others

CompletedAZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine TherapyThe purpose of this study is to assess the efficacy and safety of AZD6244 (ARRY-142886)versus capecitabine in patients with advanced or metastatic pancreatic cancer who have…NCT00372944·Alhambra, California and 16 others

RecruitingDistance-Based Exercise to Preserve Function and Prevent DisabilityThis clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to…NCT07059884·Dublin, California and 29 others

RecruitingStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaThe purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared…NCT07491445·Phoenix, Arizona and 81 others

CompletedVaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic CancerRATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.NCT01191684·Duarte, California

PreviousPage 15 of 34Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia